p53 Predictive Value for pT1-2 N0 Disease at Radical Cystectomy-Reference-Cited by-同舟云学术

p53 Predictive Value for pT1-2 N0 Disease at Radical Cystectomy

Published:2009-09 Issue:3 Volume:182 Page:907-913
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Shariat Shahrokh F.¹,Lotan Yair¹,Karakiewicz Pierre I.²,Ashfaq Raheela³,Isbarn Hendrik²,Fradet Yves⁴,Bastian Patrick J.⁵,Nielsen Matthew E.⁶,Capitanio Umberto²⁷,Jeldres Claudio²,Montorsi Francesco⁷,Müller Stefan C.⁵,Karam Jose A.¹,Heukamp Lukas C.⁸,Netto George⁹,Lerner Seth P.¹⁰,Sagalowsky Arthur I.¹,Cote Richard J.¹¹

Affiliation:

1. Department of Urology, University of Texas Southwestern Medical Center, Dallas

2. Cancer Prognostics and Health Outcomes Unit, University of Montreal, Montreal

3. Department of Pathology, University of Texas Southwestern Medical Center, Dallas

4. Centre de recherche en cancérologie de l'Université Laval, L'Hôtel-Dieu de Québec, Québec City, Quebec, Canada

5. Department of Urology, Rheinische Friedrich-Wilhelms Universität, Bonn, Germany

6. Department of Urology, Johns Hopkins Hospital, Baltimore, Maryland

7. Department of Urology, Vita-Salute University, Milan, Italy

8. Department of Pathology, Rheinische Friedrich-Wilhelms Universität, Bonn, Germany

9. Department of Pathology, Johns Hopkins Hospital, Baltimore, Maryland

10. Scott Department of Urology, Baylor College of Medicine, Houston, Texas

11. Department of Pathology, Keck School of Medicine, University of Southern California/Norris Cancer Center, Los Angeles, California

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference20 articles.

1. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients;Stein;J Clin Oncol,2001

2. Discrepancy between clinical and pathologic stage: impact on prognosis after radical cystectomy;Shariat;Eur Urol,2007

3. Surfing the p53 network;Vogelstein;Nature,2000

4. Elevated and absent pRb expression is associated with bladder cancer progression and has cooperative effects with p53;Cote;Cancer Res,1998

5. Nuclear overexpression of p53 protein in transitional cell bladder carcinoma: a marker for disease progression;Sarkis;J Natl Cancer Inst,1993

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-coding RNA transcripts, incredible modulators of cisplatin chemo-resistance in bladder cancer through operating a broad spectrum of cellular processes and signaling mechanism;Non-coding RNA Research;2024-06

2. p53 as Exemplar Next-Generation Immunohistochemical Marker: A Molecularly Informed, Pattern-Based Approach, Methodological Considerations, and Pan-Cancer Diagnostic Applications;Applied Immunohistochemistry & Molecular Morphology;2023-07-21

3. Impact of intravesical instillation of a novel biological response modifier (P-MAPA) on progress of non-muscle invasive bladder cancer treatment in a rat model;Medical Oncology;2022-01-04

4. Prognostic Value of Vascular-Expressed PSMA and CD248 in Urothelial Carcinoma of the Bladder;Frontiers in Oncology;2021-11-17

5. Perioperative Systemic Treatment for Muscle-Invasive Bladder Cancer: Current Evidence and Future Perspectives;International Journal of Molecular Sciences;2021-07-04